Stem cells in animal asthma models: A systematic review

Cytotherapy

Volumn 16, Issue 12, 2014, Pages 1629-1642

  Srour, Nadim ^a,b,c,d,e   Thébaud, Bernard ^e,f,g  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b HÔPITAL CHARLES LEMOYNE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d and a member of the Respiratory Medicine Program Committee of the College of Family Physicians of Canada   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Animal studies; Asthma; Stem cells; Systematic review; Therapy

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5; IL4 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN;

ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHITIS; CELL HYPERPLASIA; DISEASE MODEL; EOSINOPHIL COUNT; EOSINOPHILIA; EXPERIMENTAL ANIMAL; GOBLET CELL; HISTOPATHOLOGY; LUNG LAVAGE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PNEUMONIA; RESPIRATORY TRACT ALLERGY; SMOOTH MUSCLE; STEM CELL TRANSPLANTATION; THERAPY EFFECT; VASCULITIS; ANIMAL; BAGG ALBINO MOUSE; HUMAN; IMMUNOLOGY; MEDLINE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; TH2 CELL;

ANIMALIA;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-4; INTERLEUKIN-5; MEDLINE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; TH2 CELLS;

EID: 84911896174     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.08.008     Document Type: Article

References (40)

1. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B., et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. JAllergy Clin Immunol 2004, 114:40-47.
2. Grammatikos A.P. The genetic and environmental basis of atopic diseases. Ann Med 2008, 40:482-495.
3. Bell M.C., Busse W.W. Severe asthma: an expanding and mounting clinical challenge. JAllergy Clin Immunol 2013, 1:110-121. quiz 22.
4. Bonfield T.L., Nolan M.T., Lennon D.P., Caplan A.I. Defining human mesenchymal stem cell efficacy in vivo. JInflamm 2010, 7. 10.1186/1476-9255-7-51.
5. Ionescu L.I., Alphonse R.S., Arizmendi N., Morgan B., Abel M., Eaton F., et al. Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma. Am J Respir Cell Mol Biol 2012, 46:207-216.
6. Friedrich J.O., Adhikari N.K., Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. JClin Epidemiol 2011, 64:556-564.
7. Abreu S.C., Antunes M.A., Maron-Gutierrez T., Cruz F.F., Carmo L.G., Ornellas D.S., et al. Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation. Respir Physiol Neurobiol 2011, 175:153-163.
8. Abreu S.C., Antunes M.A., Maron-Gutierrez T., Cruz F.F., Ornellas D.S., Silva A.L., et al. Bone marrow mononuclear cell therapy in experimental allergic asthma: Intratracheal versus intravenous administration. Respir Physiol Neurobiol 2013, 185:615-624.
9. Nemeth K., Keane-Myers A., Brown J.M., Metcalfe D.D., Gorham J.D., Bundoc V.G., et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A 2010, 107:5652-5657.
10. Lee S.H., Jang A.S., Kwon J.H., Park S.K., Won J.H., Park C.S. Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murine asthma model. Allergy Asthma Immunol Res 2011, 3:205-211.
11. Ahmad T., Mukherjee S., Pattnaik B., Kumar M., Singh S., Rehman R., et al. Miro1 regulates intercellular mitochondrial transport and enhances mesenchymal stem cell rescue efficacy. EMBO J 2014, 33:994-1010.
12. Marinas-Pardo L., Mirones I., Amor-Carro O., Fraga-Iriso R., Lema-Costa B., Cubillo I., et al. Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma. Allergy 2014, 69:730-740.
13. Lathrop M.J., Brooks E.M., Bonenfant N.R., Sokocevic D., Borg Z.D., Goodwin M., et al. Mesenchymal stromal cells mediate aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the th17 signaling pathway. Stem Cells Translat Med 2014, 3:194-205.
14. Ogulur I., Gurhan G., Aksoy A., Duruksu G., Inci C., Filinte D., et al. Suppressive effect of compact bone-derived mesenchymal stem cells on chronic airway remodeling in murine model of asthma. Int Immunopharmacol 2014, 20:101-109.
15. Bonfield T.L., Koloze M., Lennon D.P., Zuchowski B., Yang S.E., Caplan A.I. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010, 299:L760-L770.
16. Mathias L.J., Khong S.M., Spyroglou L., Payne N.L., Siatskas C., Thorburn A.N., et al. Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells. JImmunol 2013, 191:5914-5924.
17. Sun Y.Q., Deng M.X., He J., Zeng Q.X., Wen W., Wong D.S., et al. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells 2012, 30:2692-2699.
18. Wang C.Y., Chiou G.Y., Chien Y., Wu C.C., Wu T.C., Lo W.T., et al. Induced pluripotent stem cells without c-myc reduce airway responsiveness and allergic reaction in sensitized mice. Transplantation 2013, 96:958-965.
19. Park H.K., Cho K.S., Park H.Y., Shin D.H., Kim Y.K., Jung J.S., et al. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 2010, 19:1811-1818.
20. Goodwin M., Sueblinvong V., Eisenhauer P., Ziats N.P., LeClair L., Poynter M.E., et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 2011, 29:1137-1148.
21. Kavanagh H., Mahon B.P. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy Eur J Allergy Clin Immunol 2011, 66:523-531.
22. Firinci F., Karaman M., Baran Y., Bagriyanik A., Ayyildiz Z.A., Kiray M., et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011, 11:1120-1126.
23. Ge X., Bai C., Yang J., Lou G., Li Q., Chen R. Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma. JCell Biochem 2013, 114:1595-1605.
24. Ge X., Bai C., Yang J., Lou G., Li Q., Chen R. Intratracheal transplantation of bone marrow-derived mesenchymal stem cells reduced airway inflammation and up-regulated CD4+CD25+ regulatory T cells in asthmatic mouse. Cell Biol Int 2013, 37:675-686.
25. Ou-Yang H.F., Huang Y., Hu X.B., Wu C.G. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med 2011, 236:1461-1467.
26. Abreu S.C., Antunes M.A., de Castro J.C., de Oliveira M.V., Bandeira E., Ornellas D.S., et al. Bone marrow-derived mononuclear cells vs. mesenchymal stromal cells in experimental allergic asthma. Respir Physiol Neurobiol 2013, 187:190-198.
27. Cho K.S., Park H.K., Park H.Y., Jung J.S., Jeon S.G., Kim Y.K., et al. IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 2009, 27:259-265.
28. Fu Q.L., Chow Y.Y., Sun S.J., Zeng Q.X., Li H.B., Shi J.B., et al. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy 2012, 67:1215-1222.
29. Lee J.W., Fang X., Krasnodembskaya A., Howard J.P., Matthay M.A. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011, 29:913-919.
30. Nasef A., Chapel A., Mazurier C., Bouchet S., Lopez M., Mathieu N., et al. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Express 2007, 13:217-226.
31. Aliotta J.M., Sanchez-Guijo F.M., Dooner G.J., Johnson K.W., Dooner M.S., Greer K.A., et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 2007, 25:2245-2256.
32. Lee C., Mitsialis S.A., Aslam M., Vitali S.H., Vergadi E., Konstantinou G., et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012, 126:2601-2611.
33. Glasziou P., Altman D.G., Bossuyt P., Boutron I., Clarke M., Julious S., et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 2014, 383:267-276.
34. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010, 8:e1000412.
35. Knoepfler P.S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009, 27:1050-1056.
36. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., et al. Arandomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. JAm Coll Cardiol 2009, 54:2277-2286.
37. Sng J., Lufkin T. Emerging stem cell therapies: treatment, safety, and biology. Stem Cells Int 2012, 2012:521343.
38. Wakitani S., Okabe T., Horibe S., Mitsuoka T., Saito M., Koyama T., et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. JTissue Eng Regen Med 2011, 5:146-150.
39. Lee J.S., Hong J.M., Moon G.J., Lee P.H., Ahn Y.H., Bang O.Y., et al. Along-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010, 28:1099-1106.
40. Weiss D.J., Casaburi R., Flannery R., LeRoux-Williams M., Tashkin D.P. Aplacebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013, 143:1590-1598.